Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2013-11-30
2014-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Age-dependent Effects of Flavanols on Vascular Status
NCT01639781
Interaction of Cocoa Methylxanthines With Cocoa Flavanol Related Vascular Effects
NCT02149238
Role of Flavanols In Cardiovascular Function in Healthy Aging
NCT01395277
Influence of Age on the Absorption and Metabolism of Cocoa Flavanols
NCT01790009
Role of Flavanols in Exercise and Aging
NCT01557738
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Flavanol rich product A
250 mg flavanols
Flavanol rich intervention
Flavanol intervention products (250 mg, 500 mg and 750 mg flavanols)
Flavanol free intervention
Calorically, micro- and macronutrient matched control product free of flavanols
Flavanol rich product B
500 mg flavanols
Flavanol rich intervention
Flavanol intervention products (250 mg, 500 mg and 750 mg flavanols)
Flavanol free intervention
Calorically, micro- and macronutrient matched control product free of flavanols
Flavanol rich product C
750 mg flavanols
Flavanol rich intervention
Flavanol intervention products (250 mg, 500 mg and 750 mg flavanols)
Flavanol free intervention
Calorically, micro- and macronutrient matched control product free of flavanols
Flavanol free product
flavanol free
Flavanol rich intervention
Flavanol intervention products (250 mg, 500 mg and 750 mg flavanols)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Flavanol rich intervention
Flavanol intervention products (250 mg, 500 mg and 750 mg flavanols)
Flavanol free intervention
Calorically, micro- and macronutrient matched control product free of flavanols
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* healthy male subjects (\>50 years)
Exclusion Criteria
* cardiac arrhythmia
* renal failure
* heart failure (NYHA II-IV)
* diabetes mellitus
* CRP \> 1 mg/dl
* malignant disease
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heinrich-Heine University, Duesseldorf
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Klinik für Kardiologie, Pneumologie und Angiologie
Klinik für Kardiologie, Pneumologie und Angiologie
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christian Heiss, MD
Role: PRINCIPAL_INVESTIGATOR
Division of Cardiology, Pulmonology and Vascular Medicine
Ana Rodriguez Mateos, PhD
Role: PRINCIPAL_INVESTIGATOR
Division of Cardiology, Pulmonology and Vascular Medicine
Malte Kelm, MD
Role: STUDY_CHAIR
Division of Cardiology, Pulmonology and Vascular Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Division of Cardiology, Pulmonology and Vascular Medicine
Düsseldorf, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BRANDED
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.